Summa Biotech

About Summa Biotech

Summa Biotech is a medical biotech company that is founded in 2022 and focuses on developing ground-breaking RNA-based medicines that reverse the damage of ischemic heart disease, which is a leading cause of death worldwide.

We aim restore damaged heart tissue by eliciting the regeneration of healthy cells and tissues using RNA therapeutics.

Summa Biotech’s strategy is to develop game-changing curative therapies for ischemic heart disease by leveraging academic expertise, cutting-edge disease models and fostering a culture of team excellence.

Keywords

• Heart Failure
• Regenerative Medicine
• Rna Therapeutics

Address

• Headquarters

  Klokkenbergweg 81101AS AmsterdamNoord-Holland, Netherlands

Team by function

Based on 9 public job profiles as of 4 September 2026.

• Research / R&D3
• Founder / Owner2
• Healthcare / Medical2
• Engineering / Software Development1
• Executive / C-Suite1